Drug Stocks Are the New Safe Bet in a Shaky Market - WSJ
1. Nvidia's stock declined despite strong sales performance amid cooling AI hype. 2. Healthcare sector gaining investor interest as a stable long-term growth option. 3. Investors shifting focus towards affordable healthcare stocks during economic uncertainty. 4. Big Pharma stocks outperforming the broader market despite previous underperformance. 5. High-growth tech stocks may see valuation pressure in a rotation to value.